Atlas Trials

A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment

Clinical trial NCT00785772 · TERMINATED

Trial details

NCT number
NCT00785772
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Renal Impairment
Start date
2010-03-01
Primary completion
2010-04-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.